BIOMAT Database Logo BIOMAT Database Logo

Evaluation of the in-vitro activity of Sch 29482. 1982

D Loebenberg, and G H Miller, and E L Moss, and E Oden, and R S Hare, and M Chung, and J A Waitz

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007769 Lactams Cyclic AMIDES formed from aminocarboxylic acids by the elimination of water. Lactims are the enol forms of lactams. Lactam,Lactim,Lactims
D008297 Male Males
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases

Related Publications

D Loebenberg, and G H Miller, and E L Moss, and E Oden, and R S Hare, and M Chung, and J A Waitz
Bactericidal activity of Sch 29482.
February 1982, The Journal of antimicrobial chemotherapy,
D Loebenberg, and G H Miller, and E L Moss, and E Oden, and R S Hare, and M Chung, and J A Waitz
In-vitro activity of Sch 29482--a new penem antibiotic.
February 1982, The Journal of antimicrobial chemotherapy,
D Loebenberg, and G H Miller, and E L Moss, and E Oden, and R S Hare, and M Chung, and J A Waitz
In-vitro activity of Sch 29482 against bacterial blood isolates.
February 1982, The Journal of antimicrobial chemotherapy,
D Loebenberg, and G H Miller, and E L Moss, and E Oden, and R S Hare, and M Chung, and J A Waitz
Comparative in-vitro activity of Sch 29482, a new penem antibiotic.
February 1982, The Journal of antimicrobial chemotherapy,
D Loebenberg, and G H Miller, and E L Moss, and E Oden, and R S Hare, and M Chung, and J A Waitz
Sch 29482: in-vitro antibacterial activity and susceptibility to beta-lactamases.
February 1982, The Journal of antimicrobial chemotherapy,
D Loebenberg, and G H Miller, and E L Moss, and E Oden, and R S Hare, and M Chung, and J A Waitz
In-vitro activity of Sch 29482 in comparison with other oral antibiotics.
February 1982, The Journal of antimicrobial chemotherapy,
D Loebenberg, and G H Miller, and E L Moss, and E Oden, and R S Hare, and M Chung, and J A Waitz
In-vitro activity of Sch 29482--a new oral beta-lactam antibiotic.
February 1982, The Journal of antimicrobial chemotherapy,
D Loebenberg, and G H Miller, and E L Moss, and E Oden, and R S Hare, and M Chung, and J A Waitz
Anti-staphylococcal activity of a penem, Sch 29482.
February 1982, The Journal of antimicrobial chemotherapy,
D Loebenberg, and G H Miller, and E L Moss, and E Oden, and R S Hare, and M Chung, and J A Waitz
Antibacterial activity of an oral penem, Sch 29482.
February 1982, The Journal of antimicrobial chemotherapy,
D Loebenberg, and G H Miller, and E L Moss, and E Oden, and R S Hare, and M Chung, and J A Waitz
Sch 29482, laboratory evaluation of a new penem antibiotic.
February 1982, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!